Regeneron: Scaling NGS to deliver more discoveries, faster

14 April 2017

Aris Baras and John Overton of Regeneron discuss their latest work and overall mission to explore new variations in genomes that can help explain disease. As one of the largest biotech companies in the world, Regeneron’s focus on large scale sequencing studies and finding mutations in certain genes is ultimately improving patient outcomes. Hear how they plan to utilize the NovaSeq™ 6000 System and why the introduction of this new technology is allowing them to redesign their experiments to take advantage of a whole new level of scale and output. View related videos CZ Biohub: Conducting innovative experiments with NGS Introducing NovaSeq: The Next Era in Sequencing Starts Now View related webinars See the NovaSeq 6000 System in action View related information NovaSeq 6000 System Subscribe to the Illumina video channel For Research Use Only. Not for use in diagnostic procedures. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on